Amlexanox
- Generic Name
- Amlexanox
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H14N2O4
- CAS Number
- 68302-57-8
- Unique Ingredient Identifier
- BRL1C2459K
- Background
Amlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population.
- Indication
Used as a paste in the mouth to treat aphthous ulcers (canker sores).
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients
- Conditions
- Diabetes Mellitus Type 2Non-alcoholic Fatty Liver DiseaseObesity
- Interventions
- Drug: PlaceboDrug: Amlexanox
- First Posted Date
- 2013-11-05
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 42
- Registration Number
- NCT01975935
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Amlexanox for Type 2 Diabetes and Obesity
- Conditions
- Diabetes Mellitus Type 2Non Alcoholic Fatty Liver DiseaseObesity
- Interventions
- First Posted Date
- 2013-04-29
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 7
- Registration Number
- NCT01842282
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2010-03-18
- Lead Sponsor
- Access Pharmaceuticals, Inc.
- Target Recruit Count
- 58
- Registration Number
- NCT01083875
- Locations
- 🇺🇸
University of Tennessee, Memphis, Tennessee, United States
🇺🇸University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.